nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium
|
Demyttenaere, Koen |
|
2005 |
27 |
1 |
p. 111-124 14 p. |
artikel |
2 |
A multicenter, open-label, sequential study comparingpreferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease
|
Nausieda, Paul A. |
|
2005 |
27 |
1 |
p. 58-63 6 p. |
artikel |
3 |
Antimuscarinic agents: Implications and concerns in themanagement of overactive bladder in the elderly
|
Kay, Gary G. |
|
2005 |
27 |
1 |
p. 127-138 12 p. |
artikel |
4 |
Antimuscarinic agents: Implications and concerns in the management of overactive bladder in the elderly
|
|
|
2005 |
27 |
1 |
p. 139-140 2 p. |
artikel |
5 |
Capecitabine: A review
|
Walko, Christine M. |
|
2005 |
27 |
1 |
p. 23-44 22 p. |
artikel |
6 |
CME Information
|
|
|
2005 |
27 |
1 |
p. 126- 1 p. |
artikel |
7 |
CME Test Answer Sheet and Evaluation Form
|
|
|
2005 |
27 |
1 |
p. 141- 1 p. |
artikel |
8 |
Combination oxycodone 5 mg/ibuprofen 400 mg for thetreatment of pain after abdominal or pelvic surgery in women: A randomized, double-blind, placebo- and active-controlled parallel-group study
|
Singla, Neil |
|
2005 |
27 |
1 |
p. 45-57 13 p. |
artikel |
9 |
Corrections
|
|
|
2005 |
27 |
1 |
p. 142- 1 p. |
artikel |
10 |
Editorial Board
|
|
|
2005 |
27 |
1 |
p. CO2- 1 p. |
artikel |
11 |
Efficacy and tolerability of lumiracoxib in the treatmentof osteoarthritis of the knee: A 13-week, randomized, double-blind comparison with celecoxib and placebo
|
Sheldon, Eric |
|
2005 |
27 |
1 |
p. 64-77 14 p. |
artikel |
12 |
Prevalence and correlates of potentially inappropriate prescribing among ambulatory older patients in the year 2001: Comparison of three explicit criteria
|
Viswanathan, Hema |
|
2005 |
27 |
1 |
p. 88-99 12 p. |
artikel |
13 |
Psychomotor performance in healthy young adult volunteers peceiving lormetazepam and placebo: A single-dose, randomized, double-blind, crossover trial
|
Fabbrini, Monica |
|
2005 |
27 |
1 |
p. 78-83 6 p. |
artikel |
14 |
Resolutions, national goals, and health disparities
|
Lyles, Alan |
|
2005 |
27 |
1 |
p. 86-87 2 p. |
artikel |
15 |
The bone quality framework: Determinants of bone strength and their interrelationships, and implications for osteoporosis management
|
Felsenberg, Dieter |
|
2005 |
27 |
1 |
p. 1-11 11 p. |
artikel |
16 |
The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden
|
Lindgren, Peter |
|
2005 |
27 |
1 |
p. 100-110 11 p. |
artikel |
17 |
Tigecycline: An investigational glycylcycline antimicrobialwith activity against resistant gram-positive organisms
|
Garrison, Mark W. |
|
2005 |
27 |
1 |
p. 12-22 11 p. |
artikel |